{"url_path":"/sec/lfcr/8-k/2026-03-16/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-03-16","source_url":"https://www.sec.gov/Archives/edgar/data/1005286/0001005286-26-000007-index.html","accession_number":"0001005286-26-000007","cik":"0001005286","ticker":"LFCR","issuer_name":"LIFECORE BIOMEDICAL, INC. \\DE\\","edgar_url":"https://www.sec.gov/Archives/edgar/data/1005286/0001005286-26-000007-index.html","primary_entity_key":"0001005286","primary_entity_name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"word_count":116,"has_tables":true,"body_markdown":"Item 7.01    Regulation FD.\n\nOn March 16, 2026, the Company made available on its website certain investor presentation materials (the “Investor Presentation”). A copy of the Investor Presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference in this Item 7.01.\n\nThe information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.2 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing."}